Structures of mouse SOD1 and human/mouse SOD1 chimeras.
暂无分享,去创建一个
P. Hart | Alexander B. Taylor | S. Holloway | Alexander B Taylor | P John Hart | Sai V Seetharaman | Stephen Holloway | S. Seetharaman
[1] J. Valentine,et al. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. , 2005, Annual review of biochemistry.
[2] R. Read. Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .
[3] K. Melcher. A modular set of prokaryotic and eukaryotic expression vectors. , 2000, Analytical biochemistry.
[4] P. Andersen,et al. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. , 2006, Brain : a journal of neurology.
[5] T. O’Halloran,et al. Oxygen‐induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS , 2004, The EMBO journal.
[6] Xavier Robert,et al. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins , 2003, Nucleic Acids Res..
[7] Axel T. Brunger,et al. Free R value: cross-validation in crystallography. , 1997 .
[8] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[9] Michael A Hough,et al. The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. , 2003, Journal of molecular biology.
[10] D. Borchelt,et al. A Limited Role for Disulfide Cross-linking in the Aggregation of Mutant SOD1 Linked to Familial Amyotrophic Lateral Sclerosis* , 2008, Journal of Biological Chemistry.
[11] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[12] G. Comi,et al. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype , 2008, Journal of Medical Genetics.
[13] Y. Itoyama,et al. Motor Neuron Disease in Transgenic Mice With an H46R Mutant SOD1 Gene , 2007, Journal of neuropathology and experimental neurology.
[14] S. Antonyuk,et al. Structures of the G85R Variant of SOD1 in Familial Amyotrophic Lateral Sclerosis* , 2008, Journal of Biological Chemistry.
[15] C. Dobson,et al. Protein misfolding diseases : current and emerging principles and therapies , 2010 .
[16] A. Vagin,et al. MOLREP: an Automated Program for Molecular Replacement , 1997 .
[17] G J Kleywegt,et al. xdlMAPMAN and xdlDATAMAN - programs for reformatting, analysis and manipulation of biomacromolecular electron-density maps and reflection data sets. , 1996, Acta crystallographica. Section D, Biological crystallography.
[18] R. Casareno,et al. The Copper Chaperone for Superoxide Dismutase* , 1997, The Journal of Biological Chemistry.
[19] K. Wilson,et al. Crystal structure of reduced bovine erythrocyte superoxide dismutase at 1.9 A resolution. , 1995, Journal of molecular biology.
[20] J. Danielsson,et al. Functional features cause misfolding of the ALS-provoking enzyme SOD1 , 2009, Proceedings of the National Academy of Sciences.
[21] Matteo Pellegrini,et al. Subunit asymmetry in the three‐dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis , 1998, Protein science : a publication of the Protein Society.
[22] P. Andersen,et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. , 2004, Brain : a journal of neurology.
[23] D. Eisenberg,et al. A structure-based mechanism for copper-zinc superoxide dismutase. , 1999, Biochemistry.
[24] P. Hart. Pathogenic superoxide dismutase structure, folding, aggregation and turnover. , 2006, Current opinion in chemical biology.
[25] Ericka Stricklin-Parker,et al. Ann , 2005 .
[26] T. O’Halloran,et al. Complete Loss of Post-translational Modifications Triggers Fibrillar Aggregation of SOD1 in the Familial Form of Amyotrophic Lateral Sclerosis* , 2008, Journal of Biological Chemistry.
[27] D. Borchelt,et al. Mapping superoxide dismutase 1 domains of non‐native interaction: roles of intra‐ and intermolecular disulfide bonding in aggregation , 2006, Journal of neurochemistry.
[28] Bryan F. Shaw,et al. Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. , 2007, Journal of the American Chemical Society.
[29] T. Siddique,et al. Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. , 2009, Human molecular genetics.
[30] M. Pericak-Vance,et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.
[31] K. Nakashima,et al. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification. , 2005, Brain research. Molecular brain research.
[32] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[33] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[34] D. Borchelt,et al. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.
[35] D. Borchelt,et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. , 2003, Human molecular genetics.
[36] D. Borchelt,et al. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation. , 2005, Human molecular genetics.
[37] L. Bruijn,et al. Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.
[38] D. Eisenberg,et al. Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase. , 1996, Biochemistry.
[39] D. Borchelt,et al. Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis , 2009, Experimental biology and medicine.
[40] C. Sander,et al. Errors in protein structures , 1996, Nature.
[41] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[42] J. Valentine,et al. Disrupted zinc-binding sites in structures of pathogenic SOD1 variants D124V and H80R. , 2010, Biochemistry.
[43] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[44] E. Bigio,et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Morrison,et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] P. Andersen,et al. Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models , 2007, Proceedings of the National Academy of Sciences.
[47] M. Bolognesi,et al. Crystal structure of yeast Cu,Zn superoxide dismutase. Crystallographic refinement at 2.5 A resolution. , 1992, Journal of molecular biology.
[48] J. Richardson,et al. Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. , 1980, Journal of molecular biology.
[49] Michael A Hough,et al. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. , 2006, Journal of molecular biology.
[50] P. Karplus,et al. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. , 2007, Journal of molecular biology.
[51] D. Borchelt,et al. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.
[52] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[53] I. Bertini,et al. Human SOD1 before Harboring the Catalytic Metal , 2006, Journal of Biological Chemistry.
[54] Jennifer Stine Elam,et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS , 2003, Nature Structural Biology.
[55] D. Borchelt,et al. Modulation of mutant superoxide dismutase 1 aggregation by co‐expression of wild‐type enzyme , 2009, Journal of neurochemistry.
[56] T. O’Halloran,et al. Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. , 2006, Antioxidants & redox signaling.
[57] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[58] J. Tainer,et al. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Valentine,et al. An Alternative Mechanism of Bicarbonate-mediated Peroxidation by Copper-Zinc Superoxide Dismutase , 2003, Journal of Biological Chemistry.
[60] D. Borchelt,et al. Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q. , 2009, Biochemistry.